Synergy and Collaboration
FREE ROAD MAP TO FDA WHITE-PAPER
The ITC Transporter White Paper provides detailed guidance for transporter mediated DDI studies for the seven transporters recommended in the March 17, 2010 FDA Advisory Committee vote. Get the White Paper and a Road Map Summary to help navigate it.
QUESTIONS?
Speak with one of our DMPK specialists about your needs to understand how we can help you and the results you can expect.
CONTACT US:
888-OPTIVIA (888-678-4842)
Collaborations
Optivia highly values collaborative efforts on advancing transporter biology research and expanding the utility of transporter assays in drug discovery and development.
Optivia is collaborating with Professor Leslie Z. Benet’s group at University of California, San Francisco. Funded by a joint NIH grant, this collaboration aims to evaluate the roles of transporter proteins, and the interplay between transporters and CYP enzymes on drug disposition in the liver.
Optivia also has a pilot program with a government regulatory agency on studying liver transporter polymorphism and its effect on statin drug transport.
For information on collaborating with Optivia, please contact us at (650)324-3177 ext. 11.
Optivia highly values collaborative efforts on advancing transporter biology research and expanding the utility of transporter assays in drug discovery and development.
Optivia is collaborating with Professor Leslie Z. Benet’s group at University of California, San Francisco. Funded by a joint NIH grant, this collaboration aims to evaluate the roles of transporter proteins, and the interplay between transporters and CYP enzymes on drug disposition in the liver.
Optivia also has a pilot program with a government regulatory agency on studying liver transporter polymorphism and its effect on statin drug transport.
For information on collaborating with Optivia, please contact us at (650)324-3177 ext. 11.